Gerald Burgstaller

Gerald Burgstaller is a Principal Investigator and Research Group Leader at Helmholtz Munich's Institute of Lung Health and Immunity and Comprehensive Pneumology Center (CPC). His work focuses on developing innovative immunotherapeutic technologies for chronic lung diseases, particularly Idiopathic Pulmonary Fibrosis (IPF) and Chronic Obstructive Pulmonary Disease (COPD).

• Expertise in extracellular matrix (ECM) biology
• Specializes in AI-driven drug discovery
• Develops advanced 3D/4D human disease models

His research integrates phenotypic screening with deep learning methods to identify novel molecular targets. Recent publications highlight breakthroughs in:

• RNA delivery systems for lung diseases
• Multi-rater organoid detection datasets
• Spatial nanoparticle profiling in lungs

Burgstaller leads a multidisciplinary team working on:

• Extracellular vesicle mechanisms in fibrosis
• Computational pathology analysis
• Medicinal chemistry approaches